Olokizumab (CDP-6038) is a humanized anti-IL-6 monoclonal antibody that selectively blocks the final assembly of the IL-6 signaling complex for the study of rheumatoid arthritis (RA).
Purity:
95.00%
CAS Number:
[1007223-17-7]
Target:
Interleukin|||IL Receptor
* VAT and and shipping costs not included. Errors and price changes excepted